SOMERVILLE, Mass. (AP) — SOMERVILLE, Mass. (AP) — Generate Biomedicines Inc. (GENB) on Thursday reported a loss of $67.3 million in its second quarter. The Somerville, Massachusetts-based company said it had a loss of 52 cents per share. The results missed Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 48 cents per share. The clinical-stage generative biology company poste…